Findings

What do systematic reviews say?

1,501 questions · 1,558 findings · 115 reviews · Vascular

Sort:Best matchNewestHighest certainty Download CSV

No studies found 346 · 22.2%GRADE not reported 90 · 5.8%Very low 281 · 18%Low 477 · 30.6%Moderate 313 · 20.1%High 51 · 3.3%

NSAIDs vs placebo

Minor bleeding · people with superficial thrombophlebitis of the leg

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NSAIDs vs placebo

Adverse effects of treatment · people with superficial thrombophlebitis of the leg

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fondaparinux vs placebo

Extension of ST Ultrasonography · people with ST of the leg

Fondaparinux probably leads to lower extension of ST Ultrasonography compared with placebo (moderate certainty).

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
RR 0.08 [0.03, 0.22]
1 study · 3002 participants
Moderate

Fondaparinux vs placebo

Recurrence of ST Ultrasonography · people with ST of the leg

Fondaparinux probably leads to lower recurrence of ST Ultrasonography compared with placebo (moderate certainty).

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
RR 0.21 [0.08, 0.54]
1 study · 3002 participants
Moderate

Fondaparinux vs placebo

All‐cause mortality · people with ST of the leg

Fondaparinux showed no clear difference in mortality compared with placebo (moderate certainty).

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
RR 2 [0.18, 22]
1 study · 3002 participants
Moderate

Fondaparinux vs placebo

Minor bleeding · people with ST of the leg

Fondaparinux showed no clear difference in minor bleeding compared with placebo (moderate certainty).

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
RR 1.49 [0.53, 4.17]
1 study · 2987 participants
Moderate

Fondaparinux vs placebo

Adverse effects of treatment · people with ST of the leg

Fondaparinux showed no clear difference in adverse effects of treatment compared with placebo (moderate certainty).

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
RR 1.13 [0.78, 1.65]
1 study · 2987 participants
Moderate

Prophylactic LMWH vs placebo

Symptomatic VTE · people with ST of the leg

Prophylactic LMWH showed no clear difference in symptomatic VTE compared with placebo (low certainty).

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
RR 1.22 [0.38, 3.89]
1 study · 222 participants
Low

Prophylactic LMWH vs placebo

Major bleeding · people with ST of the leg

1 finding from 1 review

Treatment for superficial thrombophlebitis of the leg 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 222 participants
Low

Intervention not reported

Success of prosthetic rehabilitation (preference) (1 day) · adults over the age of 50 with a unilateral transfemoral amputation

1 finding from 1 review

Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 10 participants
Very low

Intervention not reported

Adverse effects (1 day) · adults over the age of 50 with a unilateral transfemoral amputation

The review found no eligible studies for this question.

1 finding from 1 review

Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Supervised exercise therapy vs home exercises

Maximal treadmill walking distance after 3 months · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 351 participants
Moderate

Supervised exercise therapy vs walking advice

Self‐reported functional impairment after 3 months (Walking Impairment Questionnaire combined) Scale: 1 to 100 (higher scores indicate better walking) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 483 participants
High

Home‐based exercise therapy vs walking advice

Maximal treadmill walking distance after 3 months · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 137 participants
Moderate

Home‐based exercise therapy vs walking advice

Pain‐free walking distance · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 107 participants
Low

Home‐based exercise therapy vs walking advice

Quality of Life: SF‐36 (physical component) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Home‐based exercise therapy vs walking advice

Health‐related quality of life (mental) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Home‐based exercise therapy vs walking advice

Self‐reported functional impairment after 3 months (Walking Impairment Questionnaire combined) Scale: 1 to 100 (higher scores indicate better walking) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 79 participants
Moderate

Supervised exercise therapy vs home exercises

Pain‐free walking distance · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 322 participants
Moderate

Supervised exercise therapy vs home exercises

Quality of Life: SF‐36 (physical component) · intermittent claudication

1 finding from 1 review

Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 68 participants
Low